Table 3.
Estimated survival after total pancreatectomy (TP) according to underlying disease
| Time after surgery |
Estimated survival (95% CI) |
||||
|---|---|---|---|---|---|
| All patients (n= 47) | Pancreatic adenocarcioma (n= 20) | Pancreatic adenocarcinoma de novo (n= 10) | Pancreatic adenocarcinoma from IPMN (n= 10) | Non-invasive IPMN (n= 21) | |
| 6 months | 93% (86–100%) | 84% (70–100%) | 80% (59–100%) | 89% (71–100%) | 100% (83–100%) |
| 1 year | 80% (68–92%) | 63% (55–89%) | 40% (19–85%) | 89% (71–100%) | 95% (85–100%) |
| 2 years | 72% (59–87%) | 43% (24–76%) | 30% (12–77%) | 49% (20–100%) | 95% (85–100%) |
| 3 years | 65% (49–82%) | 34% (17–70%) | 0% (0–37%) | 49% (20–100%) | 95% (85–100%) |
IPMN, intraductal papillary mucinous neoplasms.